178 related articles for article (PubMed ID: 34956862)
1. Lobectomy Versus Sublobectomy in Stage IIIA/N2 Non-Small Cell Lung Cancer: A Population-Based Study.
Wang S; Zhang Z; Gu Y; Lv X; Shi X; Liu M
Front Oncol; 2021; 11():726811. PubMed ID: 34956862
[TBL] [Abstract][Full Text] [Related]
2. Sublobectomy versus lobectomy for long-term survival outcomes of early-stage non-small cell lung cancer with a tumor size ≤2 cm accompanied by visceral pleural invasion: a SEER population-based study.
Yu Y; Huang R; Wang P; Wang S; Ling X; Zhang P; Yu J; Wang J; Xiao J; Wang Z
J Thorac Dis; 2020 Mar; 12(3):592-604. PubMed ID: 32274125
[TBL] [Abstract][Full Text] [Related]
3. Adequate Number of Lymph Nodes Sampled May Determine Appropriate Surgical Modality for Early-Stage NSCLC: A Population-Based Real-World Study.
Ling L; Zheng H; Lin H; Ge C; Li D; Wu L; Lou Y; Jiang T; Fu J
Clin Lung Cancer; 2023 May; 24(3):e141-e151. PubMed ID: 36639280
[TBL] [Abstract][Full Text] [Related]
4. Comparison of clinical outcomes after thoracoscopic sublobectomy versus lobectomy for Stage I nonsmall cell lung cancer: A meta-analysis.
Liu Q; Wang H; Zhou D; Deng X; Min J; Dai J
J Cancer Res Ther; 2016; 12(2):926-31. PubMed ID: 27461676
[TBL] [Abstract][Full Text] [Related]
5. Sublobectomy versus lobectomy for stage I non-small-cell lung cancer, a meta-analysis of published studies.
Fan J; Wang L; Jiang GN; Gao W
Ann Surg Oncol; 2012 Feb; 19(2):661-8. PubMed ID: 21769464
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant treatment can improve prognosis in patients with non-small cell lung cancer ≤3 cm after sublobectomy: a propensity score analysis.
Ma H; Cheng J; Yu Y; Liu B; Qin J; Xing W; Luo S
J Thorac Dis; 2021 Jan; 13(1):312-321. PubMed ID: 33569211
[TBL] [Abstract][Full Text] [Related]
7. Choice of the surgical approach for patients with stage I lung squamous cell carcinoma ≤3 cm.
Chen C; Wang Y; Pan X; Fu S; Shi Y; Yang J; Wang R
J Thorac Dis; 2018 Dec; 10(12):6771-6782. PubMed ID: 30746222
[TBL] [Abstract][Full Text] [Related]
8. The Prognostic Role of PORT and EGFR Mutation Status in Completely Resected Stage IIIA/N2 Non-Small Cell Lung Cancer Patients with Postoperative Chemotherapy.
Yang H; Wang K; Li S; Li Y; Yuan L
Pathol Oncol Res; 2021; 27():1609898. PubMed ID: 34447289
[No Abstract] [Full Text] [Related]
9. Lobectomy Versus Sublobectomy in Metachronous Second Primary Lung Cancer: A Propensity Score Study.
Yang X; Zhan C; Li M; Huang Y; Zhao M; Yang X; Lin Z; Shi Y; Jiang W; Wang Q
Ann Thorac Surg; 2018 Sep; 106(3):880-887. PubMed ID: 29852145
[TBL] [Abstract][Full Text] [Related]
10. Sublobectomy versus lobectomy for stage IA (T1a) non-small-cell lung cancer: a meta-analysis study.
Liu Y; Huang C; Liu H; Chen Y; Li S
World J Surg Oncol; 2014 May; 12():138. PubMed ID: 24886396
[TBL] [Abstract][Full Text] [Related]
11. Lobectomy
Lv F; Wang B; Xue Q; Gao S
Ann Transl Med; 2021 May; 9(9):751. PubMed ID: 34268364
[TBL] [Abstract][Full Text] [Related]
12. Surgery for stage IIB-IIIB small cell lung cancer.
Huang Z; Liu Y; Wang S; Ai K; Zhang P
World J Surg Oncol; 2023 Oct; 21(1):333. PubMed ID: 37872542
[TBL] [Abstract][Full Text] [Related]
13. Sublobectomy versus lobectomy for stage I non-small cell lung cancer in the elderly.
Qiu C; Wang G; Xu J; Cui L; Dong W; Ni Y; Qu X; Du J
Int J Surg; 2017 Jan; 37():1-7. PubMed ID: 27890654
[TBL] [Abstract][Full Text] [Related]
14. Lobectomy Can Improve the Survival of Patients With Non-small Cell Lung Cancer With Lung Oligometastatic.
Wang L; Jiao F; Dong L; Li Q; Liu G; Hu X
Front Surg; 2021; 8():685186. PubMed ID: 34291078
[No Abstract] [Full Text] [Related]
15. Non-lung cancer specific mortality after lobectomy or sublobectomy in patients with stage IA non-small cell lung cancer ≤2 cm: A propensity score analysis.
Yin J; Zhao M; Lu T; Huang Y; Sui Q; Xi J; Lin Z; Xu S; Wang Q; Zhan C
J Surg Oncol; 2019 Dec; 120(8):1486-1496. PubMed ID: 31602661
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Postoperative Radiotherapy Effect on Survival of Resected Stage III-N2 Non-small Cell Lung Cancer Patients.
Gao F; Li N; Xu Y; Yang G
Front Oncol; 2020; 10():1135. PubMed ID: 32850322
[No Abstract] [Full Text] [Related]
17. A Matched Comparison Study of Uniportal Versus Triportal Thoracoscopic Lobectomy and Sublobectomy for Early-stage Nonsmall Cell Lung Cancer.
Mu JW; Gao SG; Xue Q; Zhao J; Li N; Yang K; Su K; Yuan ZY; He J
Chin Med J (Engl); 2015 Oct; 128(20):2731-5. PubMed ID: 26481738
[TBL] [Abstract][Full Text] [Related]
18. Survival after wedge resection versus lobectomy for stage IA second primary NSCLC with previous lung cancer-directed surgery.
Song C; Lu Z; Li D; Pan S; Li N; Geng Q
Front Oncol; 2022; 12():890033. PubMed ID: 36033457
[TBL] [Abstract][Full Text] [Related]
19. The impact of order with radiation therapy in stage IIIA pathologic N2 NSCLC patients: a population-based study.
Duan H; Liang L; Xie S; Wang C
BMC Cancer; 2020 Aug; 20(1):809. PubMed ID: 32847544
[TBL] [Abstract][Full Text] [Related]
20. Propensity score-matching analysis of postoperative radiotherapy for stage IIIA-N2 non-small cell lung cancer using the Surveillance, Epidemiology, and End Results database.
Wei S; Xie M; Tian J; Song X; Wu B; Liu L
Radiat Oncol; 2017 Jun; 12(1):96. PubMed ID: 28610591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
